Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
GI

GILD

Market Closed

Gilead Sciences, Inc.

NASDAQHealthcareDrug Manufacturers - General
US
17.00K employees
CEO: Daniel O'Day
Founded: 1992
$168.08
+$0.00(+NaN%)
Market Cap
208.48B
Beta
0.36
52W Range
N/A
Dividend Yield
1.93%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Gilead Sciences trades 20% above a high-confidence fair value of $134.40, indicating potential overvaluation despite excellent profitability and efficiency scores. Monte Carlo analysis shows high volatility and downside risk, with a median value below the current price. Valuation methods converge on mid-to-high $100s, reflecting mixed signals on growth and leverage concerns.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore GILD

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

GILD in the Healthcare

Mega Cap
Healthcare

Browse sector stocks →

Drug Manufacturers - General

Browse industry stocks →